NorthX Biologics and Demeetra today announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, ...
Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of ...
PHC Corporation's Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter "PHCbi"), a global provider of laboratory sample storage and cell cultivation solutions ...
VIA's leaders say eliminating fare collection would imperil funding for its planned rapid transit lines, known as the Green ...
OmniAb, Inc. (NASDAQ:OABI) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good afternoon, and welcome to OmniAb, Inc.’s First — Fourth Quarter 2025 Financial Results and Business Update ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsKyle Pilkington - Chief Legal OfficerQichao Hu - ...
Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...
10d
Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates
Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11)Reports ...
Cash Burn -- $50.2 million in 2025, an improvement from $57.8 million in 2024 due to lower headcount and development costs.
Comprehensive VAX-31 Adult Phase 3 Clinical Program, Finalized in Consultation and Alignment with FDA, Advances with Three Phase 3 Studies Underway to Support Planned BLA Submission ...
German Leibniz Institute DSMZ makes WHO-listed fungi available to researchers worldwide BRAUNSCHWEIG, LOWER SAXONY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results